ARTV vs J · $37.3M cap vs P/E 36, rev $4.08B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
ARTV currently screens at market cap $37.3M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ARTV and J stock pages for the full models.
Not investment advice.